STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Completed
- Generalized Anxiety Disorder
- Placebo
- Vilazodone
- Birmingham, Alabama
- +35 more
2019-12-04
Dec 4, 2019F
Completed
- Major Depressive Disorder
- Placebo
- Vilazodone
- Imperial, California
- +51 more
2019-12-06
Dec 6, 2019F
Completed
- Generalized Anxiety Disorder
- Placebo
- Vilazodone
- Birmingham, Alabama
- +36 more
2019-12-04
Dec 4, 2019U
Completed
- Bipolar Disorder
- Lithium Carbonate
- +29 more
- Albuquerque, New MexicoChristophe G Lambert
2021-09-29
Sep 29, 2021F
Completed
- Major Depressive Disorder
- Vilazodone
- +2 more
- Birmingham, Alabama
- +59 more
2019-09-11
Sep 11, 2019F
Completed
- Major Depressive Disorder
- Birmingham, Alabama
- +55 more
2019-09-10
Sep 10, 2019U
Completed
- Memory Impairment
- Vilazodone
- +2 more
- Dallas, TexasUT Southwestern Medical Center
2019-03-29
Mar 29, 2019U
Completed
- Major Depressive Disorder
- Vilazodone; Viibryd
- Paroxetine; Paxil
- Los Angeles, CaliforniaUCLA Semel Institute
2018-04-12
Apr 12, 2018O
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
- Portland, Oregon
- +1 more
2021-09-23
Sep 23, 2021N
Active, not recruiting
- Adult Solid Neoplasm
- +4 more
- Diagnostic Laboratory Biomarker Analysis
- +3 more
- Scottsdale, Arizona
- +3 more
2022-03-15
Mar 15, 2022N
Completed
- Stage IV Pancreatic Cancer
- cixutumumab
- +2 more
- Jonesboro, Arkansas
- +145 more
2022-01-13
Jan 13, 2022N
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Dasatinib
- +2 more
- Nashville, TennesseeVanderbilt University/Ingram Cancer Center
2021-12-15
Dec 15, 2021C
Recruiting
- Soft Tissue Sarcoma
- Anlotinib hydrochloride capsule
- +2 more
- Beijing, Beijing, China
- +2 more
2022-02-16
Feb 16, 2022M
Active, not recruiting
- Metastatic Urothelial Carcinoma
- +2 more
- Doxorubicin Hydrochloride
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-01-05
Jan 5, 2022N
Completed
- Separation Anxiety Disorder
- Vilazodone
- Placebo
- New York, New YorkNew York State Psychiatric Institute
2018-02-06
Feb 6, 2018N
Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
- Rochester, MinnesotaMayo Clinic in Rochester
2021-11-27
Nov 27, 2021N
Active, not recruiting
- Ovarian Serous Tumor
- +3 more
- Berzosertib
- +2 more
- Phoenix, Arizona
- +16 more
2022-03-23
Mar 23, 2022B
Completed
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +5 more
- gemcitabine hydrochloride
- bendamustine hydrochloride
- Atlanta, Georgia
- +1 more
2021-10-21
Oct 21, 2021A
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- Ascorbic Acid
- Pazopanib Hydrochloride
- Peoria, Illinois
- +4 more
2022-03-18
Mar 18, 2022C
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
- Birmingham, Alabama
- +78 more
2022-03-21
Mar 21, 2022A
Active, not recruiting
- Pancreatic Adenocarcinoma
- +3 more
- Fluorouracil
- +5 more
- Bronx, New YorkMontefiore Medical Center-Weiler Hospital
2021-08-20
Aug 20, 2021N
Active, not recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Non-Small Cell Cancer AJCC v7
- Cabozantinib S-malate
- +2 more
- Scottsdale, Arizona
- +368 more
2022-03-19
Mar 19, 2022C
Recruiting
- Recurrent Anaplastic Astrocytoma
- +6 more
- Carboxylesterase-expressing Allogeneic Neural Stem Cells
- +4 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-02-17
Feb 17, 2022N
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Irinotecan Hydrochloride
- +3 more
- New Haven, Connecticut
- +4 more
2022-01-19
Jan 19, 2022N
Active, not recruiting
- Pancreatic Acinar Cell Carcinoma
- +8 more
- 3-Dimensional Conformal Radiation Therapy
- +8 more
- Mobile, Alabama
- +698 more
2022-03-19
Mar 19, 2022